Joseph Edelman

CIK: 0001164426

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LONA

LeonaBio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

LONA
LeonaBio, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
LONA
LeonaBio, Inc.
Apr 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
ATHA
Athira Pharma, Inc.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20.9K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Apr 9, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
May 30, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	20,900	-	-	Direct

1-3 of 3 transactions

About EDELMAN JOSEPH

EDELMAN JOSEPH (SEC CIK 0001164426) files insider reports with the SEC as Director of LeonaBio, Inc. (LONA).

Signal8 holds 3 ownership filings by EDELMAN JOSEPH, all Form 4s, filed between Jun 3, 2025 and Jun 24, 2026. Those filings report 3 transactions, from May 30, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on EDELMAN JOSEPH's filings is in BOTHELL, WA.

Recent filings by EDELMAN JOSEPH

Jun 23, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Apr 9, 2026: Grant or award of LONA derivative securities (Form 4, code A).
May 30, 2025: Grant or award of ATHA derivative securities (Form 4, code A).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes